Gossamer Bio, Inc. (FRA:4GB)
Germany
· Delayed Price · Currency is EUR 2.860
+0.310 (12.16%)
At close: Dec 4, 2025
Gossamer Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 44.05 | 114.7 | - | - | - | - | Upgrade
|
| Gross Profit | 44.05 | 114.7 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 36.12 | 36.13 | 38.46 | 47.61 | 45.78 | 49.73 | Upgrade
|
| Research & Development | 161.27 | 138.49 | 135.3 | 170.92 | 170.27 | 160.85 | Upgrade
|
| Operating Expenses | 197.39 | 174.62 | 173.76 | 218.53 | 216.05 | 210.58 | Upgrade
|
| Operating Income | -153.34 | -59.92 | -173.76 | -218.53 | -216.05 | -210.58 | Upgrade
|
| Interest Expense | -10.98 | -11.52 | -13.51 | -13.88 | -19.44 | -12.67 | Upgrade
|
| Interest & Investment Income | 0.78 | 1.78 | 2 | 1.58 | 0.76 | 3.44 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.02 | 0.96 | 6.01 | 0.11 | 1.14 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | -165.56 | -68.7 | -179.27 | -230.72 | -233.59 | -219.88 | Upgrade
|
| Gain (Loss) on Sale of Investments | 13.06 | 13.06 | 9.45 | 1.41 | -0.34 | -0.1 | Upgrade
|
| Pretax Income | -158.57 | -55.64 | -179.82 | -229.38 | -234 | -243.36 | Upgrade
|
| Income Tax Expense | -2.41 | 0.89 | - | - | - | - | Upgrade
|
| Net Income | -156.16 | -56.53 | -179.82 | -229.38 | -234 | -243.36 | Upgrade
|
| Net Income to Common | -156.16 | -56.53 | -179.82 | -229.38 | -234 | -243.36 | Upgrade
|
| Shares Outstanding (Basic) | 227 | 226 | 153 | 85 | 75 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 227 | 226 | 153 | 85 | 75 | 69 | Upgrade
|
| Shares Change (YoY) | 0.46% | 48.23% | 80.46% | 13.00% | 9.24% | 25.16% | Upgrade
|
| EPS (Basic) | -0.69 | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 | Upgrade
|
| EPS (Diluted) | -0.69 | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 | Upgrade
|
| Free Cash Flow | -158.51 | -3.47 | -159.16 | -187.44 | -190.44 | -177.86 | Upgrade
|
| Free Cash Flow Per Share | -0.70 | -0.01 | -1.04 | -2.22 | -2.54 | -2.60 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | - | - | - | Upgrade
|
| Operating Margin | -348.10% | -52.24% | - | - | - | - | Upgrade
|
| Profit Margin | -354.50% | -49.28% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -359.84% | -3.02% | - | - | - | - | Upgrade
|
| EBITDA | -153.22 | -59.09 | -172.15 | -216.7 | -214.31 | -209.17 | Upgrade
|
| EBITDA Margin | - | -51.51% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.13 | 0.83 | 1.61 | 1.83 | 1.74 | 1.41 | Upgrade
|
| EBIT | -153.34 | -59.92 | -173.76 | -218.53 | -216.05 | -210.58 | Upgrade
|
| EBIT Margin | - | -52.24% | - | - | - | - | Upgrade
|
| Revenue as Reported | 44.05 | 114.7 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.